EyePACS Grading System (Part 3): Detecting Proliferative (Neovascular) Diabetic Retinopathy. George Bresnick MD MPA Jorge Cuadros OD PhD

Similar documents
EyePACS Grading System (Part 2): Detecting Presence and Severity of Background (Non-Proliferative) Diabetic Retinopathy Lesion

Marcus Gonzales, OD, FAAO Cedar Springs Eye Clinic

Diabetic Retinopathy. Barry Emara MD FRCS(C) Giovanni Caboto Club October 3, 2012

The Natural History of Diabetic Retinopathy and How Primary Care Makes A Difference

PART 1: GENERAL RETINAL ANATOMY

DIABETIC RETINOPATHY

Diabetic Retinopatathy

Grand Rounds: Interesting and Exemplary Cases From Guanajuato and Djibouti

Diabetic Retinopathy

Diagnosis and treatment of diabetic retinopathy. Blake Cooper MD Ophthalmologist Vitreoretinal Surgeon Retina Associates Kansas City

FRANZCO, MD, MBBS. Royal Darwin Hospital

Jay M. Haynie, O.D.; F.A.A.O. Olympia Tacoma Renton Kennewick Washington

Diabetic Retinopathy A Presentation for the Public

INTRODUCTION AND SYMPTOMS

Clinically Significant Macular Edema (CSME)

The Human Eye. Cornea Iris. Pupil. Lens. Retina

Diabesity A Public Health Crisis: AOA Evidence Based Translation to Care Series

Diabetic Retinopathy Screening in Hong Kong. Dr. Rita Gangwani M.S, FRCS (Ophth), FCOphth(HK), FHKAM Eye Institute, The University of Hong Kong

Medical Retina 2011 Nicholas Lee

Diabetic Management beyond traditional risk factors and LDL-C control: Can we improve macro and microvascular risks?

Eyes on Diabetics: How to Avoid Blindness in Diabetic Patient

Central Mersey Diabetic Retinopathy Screening Programme. Referring patients for Diabetic Retinopathy Screening

Diabetic and the Eye: An Introduction

Diabetic Retinopathy

Brampton Hurontario Street Brampton, ON L6Y 0P6

Diabetic Retinopathy

ZEISS AngioPlex OCT Angiography. Clinical Case Reports


DIABETES AND YOUR EYES. Presented by Dr. Andrea Hagler

THE ROLE OF anti-vegf IN DIABETIC RETINOPATHY AND AGE RELATED MACULAR DEGENERATION

Outline. Preventing & Treating Diabetes Related Blindness. Eye Care Center Doctors. Justin Kanoff, MD. Eye Care Center of Northern Colorado

Facts About Diabetic Eye Disease

A Systematic Approach to Diabetic Photo Reading

OCT Angiography in Primary Eye Care

RANZCO Screening and Referral Pathway for Diabetic Retinopathy #

X-Plain Diabetic Retinopathy Reference Summary

Diabetic Retinopathy WHAT IS DIABETIC RETINOPATHY? WHAT CAUSES DIABETIC RETINOPATHY? WHAT ARE THE STAGES OF DIABETIC RETINOPATHY?

Mild NPDR. Moderate NPDR. Severe NPDR

SUPPLEMENTARY DATA. Supplementary Table 1. Characteristics of Subjects.

Diabetes and Eye Health more than meets the eye Vision Initiative - in association with PSA

New Developments in the treatment of Diabetic Retinopathy

OCCLUSIVE VASCULAR DISORDERS OF THE RETINA

DIABETIC RETINOPATHY (DR) PREFERRED PRACTICE PATTERNS (PPP) Philippines 2016

7.1 Grading Diabetic Retinopathy

Factors Influencing the Development of Visual Loss in Advanced Diabetic Retinopathy

Understanding Diabetic Retinopathy

PROGRESSION OF DIABETIC RETINOPATHY FOLLOWING CATARACT SURGERY

Documentation, Codebook, and Frequencies

Preventing Avoidable Vision loss from Diabetic Retinopathy in Indian Country

Epidemiology and Pathophysiology of Diabetic Retinopathy

Diabetes & Your Eyes

Clinical Trials in Diabetic Retinopathy. Harry W. Flynn Jr., M.D. Nidhi Relhan Batra, M.D.

What is diabetes? Ocolusystemic Disease Essen6als. Statistics, cont. Statistics. Statistics. The Diabetes Epidemic 9/5/12

A Patient s Guide to Diabetic Retinopathy

Guidelines for the Management of Diabetic Retinopathy for the Internist

Diabetic retinopathy damage to the blood vessels in the retina. Cataract clouding of the eye s lens. Cataracts develop at an earlier age in people

Sponsored by. Shared care and referral pathways. Part 2: diabetes screening leading from the front

Diabetic Eye Disease

Management of diabetic eye disease: an overview

Posterior Segment Update

Diabetic Eye Disease Visual Recognition & Interpretation of Clinical Signs

DIABETIC RETINOPATHY, A

Amber Priority. Image Library

Diabetic Retinopathy

National Diabetes Retinal Screening Grading System and Referral Guidelines

The Diabetic Retinopathy Clinical Research Network. Management of DME in Eyes with PDR

American Academy of Optometry Irreversible Vision Loss during Pregnancy: Clinical Picture of Diabetic Macular Ischemia

Diabetic Retinopathy: Managing the Extremes. J. Michael Jumper, MD West Coast Retina

Diabetic Retinopathy

Retinal Vein Occlusion

Diabetic Retinopathy: A Concise Review

Optical Coherence Tomography in Diabetic Retinopathy. Mrs Samantha Mann Consultant Ophthalmologist Clinical Lead of SEL-DESP

Diabetic eye disease. Diabetic retinopathy. Sam S. Dahr, M.D. Retina Center of Oklahoma.

Diabetic Retinopathy Clinical Research Network

Treatment of Diabetic Macular Edema without Intravitreal injections

Dr Dianne Sharp Ophthalmologist Retina Specialists, Parnell Greenlane Clinical Centre

Measures have been taken, by the Utah Department of Health, Bureau of Health Promotions, to ensure no conflict of interest in this activity.

Introduction How the eye works

Common Causes of Vision Loss

Long-Term Visual Outcome in Proliferative Diabetic Retinopathy Patients After Panretinal Photocoagulation

10/8/13. the diabetes epidemic: strategies for saving sight. financial disclo$ure. unlabeled-investigative use disclosure

Spontaneous Regression of Neovascularization at the Disc in Diabetic Retinopathy

The Foundation WHAT IS THE RETINA? continued next page. RETINA HEALTH SERIES Facts from the ASRS

Factors Associated with Visual Outcome after Photocoagulation for Diabetic Retinopathy

Retina of Auburn & Metro-Columbus

Effects of an Intravitreal Bevacizumab Injection Combined With Panretinal Photocoagulation on High-Risk Proliferative Diabetic Retinopathy

The Foundation WHAT IS THE RETINA?

Diabetes Mellitus. Disorder of metabolism (Carb, Prot & Fat) Due to Absolute/relative deficiency of insulin. Characterized by hyperglycemia.

Overview. Ocular Manifestations in Diabetes. Diabetic Classification. What is Evidence Based Practice? Blood Sugar. Blood Sugar 9/17/2018

Vascular Disease Ocular Manifestations of Systemic Hypertension

Serious Eye diseases, New treatments. Mr. M. Usman Saeed MBBS, FRCS, FRCOphth Consultant Ophthalmologist

Diabetic Retinopathy Clinical Research Network

A LOOK INSIDE DIABETIC EYE DISEASE

Retinal Complications of Obstructive Sleep Apnea A Growing Concern!

Slide notes: The major chronic complications of diabetes mellitus are described here. Among these, microvascular complications have an important

Central venous occlusion

Diabetic Retinopathy What You Should Know. U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Eye Institute

Diabetic Retinopathy Clinical Research Network

Control of Systemic Factors Can Preserve Vision in Diabetic Retinopathy

Front Line Diabetic Retinopathy What Not to Miss and Why

Transcription:

EyePACS Grading System (Part 3): Detecting Proliferative (Neovascular) Diabetic Retinopathy George Bresnick MD MPA Jorge Cuadros OD PhD

Anatomy of the eye:

3 Normal Retina Retinal Arcades Macula Optic Nerve

Severe Nonproliferative Retinopathy (NPDR) 4 Latin American male, DM II X 12 years, Last eye exam 5 years ago

High-Risk Markers for Progression to Proliferative Retinopathy: Early Treatment of Diabetic Retinopathy Study Ischemic Retinal Lesion Extensive retinal hemorrhages (HMA) Progression rate to PDR (1 yr) 48% Venous beading (VB) 51% Intraretinal Microvascular Abnormalities (IRMA) Cotton Wool Spots (CWS) 44% No sig. increase

Proliferative Diabetic Retinopathy (PDR) Fibrovascular tissue on the inner surface of the retina and into the vitreous. Major cause of severe visual loss in diabetes Vitreous hemorrhage Macular traction Retinal detachment Courtesy of Fred Hollows Foundation NZ

Statistics from EyePACS Prevalence of PDR in our clinics: 6228 encounters with detected PDR 2.5% of entire database (252,000 encounters) Treatments for PDR: Laser in at least one eye: 2754 (44% of diagnosed PDR) Laser in both eyes: 1303 (21% of diagnosed PDR) Most patients detected with PDR in EyePACS don t know they have it.

8 Neovascularization (New Blood Vessels) 49 year old Caucasian male, DM II X 13 years, IDDM X 10 years, subjective DM control: Good ; last eye exam: more than 5 years

Proliferative Diabetic Retinopathy (PDR) Review the fundus lesions found in PDR Emphasize retinal ischemia stimulus for PDR Eyes with PDR at increased risk for vision loss

Fibrovascular Proliferation PDR New vessels Optic disc (NVD) Elsewhere (NVE) Fibrous proliferation Vitreous hemorrhage (VH)/preretinal hemorrhage (PRH)

NVD (Neovascularization of the disc) Fronds of new vessels emanate from optic disc (Arrows)

NVE (Neovascularization elsewhere) NVE Tuft of new vessels growing from feeding vessels

Significance of new vessels on the optic disc (NVD) NVD are a response to widespread retinal ischemia (lack of oxygen) NVD=High Risk for severe visual loss without treatment (DRS Results)

Significance of new vessels elsewhere (NVE) Reflect localized retinal ischemia High Risk for visual loss without treatment if: Extensive Associated with vitreous hemorrhage/preretinal hemorrhage

Fibrovascular Proliferation PDR New vessels optic disc (NVD) Elsewhere (NVE) Fibrous proliferation Vitreous hemorrhage (VH)/preretinal hemorrhage (PRH)

Fibrous Tissue Proliferation Accompanies new vessels May contract and cause: Localized retinal detachment Tractional displacement of macula

Fibrous tissue proliferation Localized retinal detachment Retina detached at base of elevated FP above (arrows)

Fibrovascular Proliferation PDR New vessels optic disc (NVD) Elsewhere (NVE) Fibrous proliferation Vitreous hemorrhage (VH)/preretinal hemorrhage (PRH)

Vitreous Hemorrhage (VH) Cloudy view of retina due to bleeding into the vitreous cavity

Preretinal Hemorrhage Boat-shaped PRH Lower edge of PRH below confined by curvilinear limit of posterior vitreous detachment (arrows)

High Risk PDR Diabetic Retinopathy Study (DRS) High risk for severe vision loss without laser 50% Reduction in severe vision loss with laser* Any one of the following: >=Moderate NVD with or without VH Mild NVD with VH >=Moderate NVE with VH * High Risk PDR generally requires prompt PRP laser treatment.

Proliferative Diabetic Retinopathy (PDR) Pathophysiology Stimulated by retinal ischemia Mediated by vascular endothelial growth factor (VEGF) Inhibited by Panretinal photocoagulation (PRP) Intravitreal anti-vegf factors (e.g., Avastin)

EyePACS Grading Template

NEW VESSELS (NV) OR FIBROUS PROLIFERATION (FP)? New vessels (NV) or fibrous proliferation (FP) present? no ( ) yes ( ) Cannot grade ( ) Consider NV on the disc (NVD) or elsewhere (NVE). Answer yes, if FP likely to be a frond originating from neovascular growth. Answer no, if FP likely to be fibrous (or glial) tissue from another condition e.g., epiretinal membrane; congenital glial remnant on optic disc.

Case 54360 NVD NVD

34 yr. old African American DM II X 5 yrs, HbA1c= 8.0 Lifelong Medical Clinic, 5/22/2014 NVE NVE

FP superiorly-no obvious NV Case 50276

EyePACS Grading Template

PRERETINAL HEMORRHAGE (PRH) OR VITREOUS HEMORRHAGE (VH)? Preretinal hemorrhage (PRH) or vitreous hemorrhage (VH) present? no ( ) yes ( ) Cannot grade ( ) Consider hemorrhage on the surface of the retina (preretinal space) and/or hemorrhage into the vitreous. Answer yes, even if hazy image precludes grading of other lesions of DR if haze is thought to be due to PRH and/or VH.

Preretinal Hemorrhages Lower edge of PRH below confined by curvilinear limit of posterior vitreous detachment (arrows) Boat-shaped PRH

Vitreous Hemorrhage Case 44675 VH

Questions 9, 10 Laser Scars?

LASER SCARS? Panretinal laser scars present? no ( ) yes ( ) Cannot grade ( ) Consider laser scars usually between 200 microns and 500 microns in diameter, and located beyond the posterior pole The presence of PRP scars will be considered presumptive evidence of prior PDR in the automated computer algorithm Patients who have had PRP are assumed to need continued follow up retinal care unless explicitly discharged.

Panretinal Photocoagulation (PRP)

Case 46712 PRP Laser Scars

What happens when patients are not treated in time?

24 year old Latin American female Image from EyePACS visit on 1/31/2006: HbA1c 12.6 Pregnant DM Type 1 since 7 months Advised to have close follow up due to pregnancy. Pregnancy accelerates retinopathy Type 1 DM usually has no retinopathy for first 5 years. Prominent IRMA

Case 2: 24 year old Latin American female Image from EyePACS visit on 7/16/2009: HbA1c 9.3 Pregnant Per pt, around July 4th, started seeing "webs" on the right eye. Referred for treatment within one week.

24 year old Latin American female New Blood Vessels HbA1c = 9.5 Meds: prenatal vitamins, humalog/nph insulin Photographed on 9/21/2011 at 12:21 PM

Retinal Detachment April 14, 2014 44 yr. old Latin American male 2 yrs with DM II HbA1c = 10.9 Other eye is blind

Retinal Detachment October 2, 2013 30 yr. old African American male 11-15 yrs with DM II Left eye treated 8/2013 Photographer: Per pt. he is able to see straight, but on his right side of his right eye is blurry and shaped like a cone.

Retinal Detachment June 24, 2013 49 yr. old Latin American male 4 yrs with DM II HbA1c = 11.7 Photographer: patient states cannot follow fixation light

Iris Neovascularization November 4, 2013 58 yr. old Caucasian female 6-10 yrs with DM II HbA1c = 7.8 Stopped seeing retinal specialist due to change in insurance

Iris Neovascularization May 20, 2014 60 yr. old Latin American male 6-10 yrs with DM II HbA1c = 8.3 Urgent referral (within one day, if possible) Very painful

Iris Neovascularization October 24, 2013 55 yr. old Latin American male 11-15 yrs with DM II IDDM for 1 year Permanently blind

Preventing blindness from PDR Diagnosis and treatment of PDR can prevent 50% of severe vision loss in advanced diabetic retinopathy EARLY diagnosis and treatment of PDR can prevent 90% of severe vision loss. - Center for Disease Control If a patient waits until visual symptoms arise in order to be treated, then it may be too late..

For more information about EyePACS certification for interpreting retinal images, please visit: https://www.eyepacs.org/consultant/ Thank You! www.eyepacs.com contact@eyepacs.org 800-228-6144